RecruitingNot ApplicableNCT07123181

Oregano and Basil Leaves and Coronary Artery Disease

Effects of Increasing Polyphenol Intake by Consumption of Oregano and Basil Leaves on Plasma Inflammatory and Lipid Factors and Total Urinary Polyphenol in Patients With Unstable Angina


Sponsor

Shahid Beheshti University of Medical Sciences

Enrollment

70 participants

Start Date

Sep 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The present study will examine the effects of increasing dietary polyphenol intake by consumption of oregano and basil leaves, on plasma inflammatory and lipid factors and total urinary polyphenol levels in patients who have recently had unstable angina.


Eligibility

Min Age: 30 YearsMax Age: 75 Years

Inclusion Criteria1

  • Patients diagnosed with unstable angina

Exclusion Criteria5

  • Patients diagnosed with STEMI
  • Patients undergoing coronary artery bypass grafting
  • Liver cirrhosis and advanced chronic kidney disease (CKD 5)
  • Having known inflammatory and autoimmune diseases, such as inflammatory bowel disease (IBD) and rheumatoid arthritis, or taking glucocorticoid medications
  • Pregnancy or breastfeeding

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERControl (Standard treatment)

Patients receive standard medical treatment.

OTHERHigher polyphenol intake by consumption of oregano and basil

Patients consume 4-5 grams of dried oregano and 4-5 grams of dried basil leaves daily for two months in addition to their usual medical treatment.


Locations(1)

Imam Husain hospital

Tehran, Tehran Province, Iran

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07123181


Related Trials